Australia, April 18 -- Anthia Life Sciences Pty. Ltd., owns the trademark (2585199) for 'Arzestra' till Sept. 9, 2035.
Status: registered:
Registered/protected
Classes: 5 [drugs for medical use; drugs for medical purposes; pharmaceutical preparations; pharmaceutical and medical preparations; medicines for human use; medicines for human purposes; medicine; medicines; pharmaceuticals; pharmaceutical products for use by humans; pharmaceutical drugs; pharmaceutical pills; therapeutic drugs and agents; pharmaceutical preparations and substances; combined chemical preparations used for the medical termination of pregnancies in humans.] and 44 [consultancy relating to health care; consultancy services relating to health care; consultancy services relating to health; provision of medical information; medicine information services; provision of health care information by telephone and the Internet; providing health information via a website; health counseling; healthcare; provision of health care services; providing medical treatment; provision of medical treatment; medical services; medical treatment services; medical and healthcare clinics; medical treatment services provided by clinics and hospitals; providing healthcare services; prescription of medicines; medical, medicinal and pharmaceutical consultancy; medical and healthcare clinic services; medical clinic services; medical and health care services; healthcare services; medical counselling; family planning services]
Type of Mark: Word
Date of Acceptance: Nov. 28, 2025
Registration Advertised: April 17
For further details contact Argyll Law.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2585199.
Disclaimer: Curated by HT Syndication.
